GrowingStockReport.com

NASDAQ Active Stock Watch List: Myriad Genetics Inc. (NASDAQ:MYGN) and Galena Biopharma, Inc. (NASDAQ:GALE) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/03/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Myriad Genetics Inc. (NASDAQ:MYGN) and Galena Biopharma, Inc. (NASDAQ:GALE).

Myriad Genetics Inc. (NASDAQ:MYGN) a molecular diagnostic company that focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States closed down in its previous session (-9.31%) on 9,994,715 shares traded after Myriad Genetics Sued On Gene Patents. Myriad Genetics Inc. (NASDAQ:MYGN) is currently down (-36.58%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Myriad Genetics Inc. (NASDAQ:MYGN)

Galena Biopharma, Inc. (NASDAQ:GALE) a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care closed up in its previous session (+12.25%) on 12,123,068 shares traded. Galena Biopharma, Inc. (NASDAQ:GALE) is currently up (+205.41%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Galena Biopharma, Inc. (NASDAQ:GALE)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com